Home
Industry Reports
Pharmaceuticals and Healthcare

Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits

Published: Jun-2012 Report Code: GBIHC237MR Report Format: Electronic PDF

Description

Inquire Before Buying

GBI Research, the leading business intelligence provider, has released its new report “Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits”. It analyzes the overall Supply Chain Management (SCM) scenario and provides profiles of the leading participants in the pharmaceutical supply chain in the US. The report is built using data and information sourced from proprietary databases, as well as primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The top three wholesalers in the US, AmerisourceBergen Corporation, Cardinal Health and McKesson Corporation, accounted for 86.7% of the overall US pharmaceutical market in 2011 and combined revenue of $295.2 billion. Various supply chain models are followed across the pharmaceutical industry, such as traditional wholesaler models, limited distribution models and direct distribution models. Pharmaceutical companies are now focusing on supply chains as a value-adding process rather than viewing them as a money drain, which was the scenario in the past. Managing a supply chain is a complicated task, as there are a number of issues that can affect performance and disrupt product and information flow. Counterfeits have emerged as the greatest threat to the smooth functioning of the supply chain in the US. The recent case of fake Avastin entering the legitimate supply chain has raised concerns over administrative abilities, and the Food and Drug Administration (FDA) has taken numerous steps to track and trace counterfeits. The state of California has implemented the E-pedigree model and announced implementation deadlines for wholesalers, manufacturers and pharmacies. In 2009, 1,742 drugs were recalled by FDA, for a range of reasons such as quality of raw materials, defective labeling, packaging issues and contaminated products. Over-the-counter (OTC) and generic products account for the most recalls.

Scope

Segmentation of the pharmaceutical supply industry in terms of major components such as manufacturer, wholesaler and pharmacy
Key issues facing the pharmaceutical supply chain in the US
Analysis of strategies adopted by pharmaceutical manufacturers and wholesalers to remain competitive
Key parameters which are considered for rejuvenating the existing supply chain
Profiles of key pharmaceutical supply chain management companies
Emerging technologies being developed for anti-counterfeit operations.

Reasons to Buy

Understand the existing market scenario
Analyze the requirements for regulatory compliance for pharmaceutical supply chain management
Pinpoint key uncertainties facing the pharmaceutical supply chain in the US
Develop strategies for implementing lean technology in the pharmaceutical supply chain
Develop risk mitigation strategies

Related Industry Reports

License Details

Single User License:

$3,500.00

Site License:

$7,000.00

Global License:

$10,500.00

Search Help
To run a quick Search on GBI Research site, enter the keywords for which you wish to search. By default, quick search will return documents which have at least any one of the words you have queried (an automatic "Or" search).

Detailed Functionality
• Higher relevance will be given to those documents where your search terms appear a greater number of times. Avoid using words such "and" or "or".

Phrase Searches
• You can search for a phrase by typing the keywords in quotation marks (""). For example, typing "Global Energy Efficient Lighting" will only return documents that contain this exact phrase.

Or Queries
• By default, search returns documents that include any of your search terms. There is no need to include or between terms. The order in which the terms are typed will affect the search results.

And Queries
• Adding and between two search terms means the search will return documents including both terms, whether they are listed together or not.


	Electronic PDF copy delivered via email. Report can be used by individual purchaser only.


	Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.


	Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.